Journal
PHARMACOLOGY & THERAPEUTICS
Volume 88, Issue 2, Pages 187-196Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/S0163-7258(00)00091-7
Keywords
asthma; Th2 cell; Th1 cell; immunotherapy; GATA-3
Categories
Ask authors/readers for more resources
Asthma is a chronic inflammatory disease of the bronchial ah-ways. Current research in humans and animals suggests that T-helper type 2 (Th2) cells and the cytokines they elaborate cause many of the pathophysiologic abnormalities characteristic of the disease. We review the evidence implicating Th2 cells in asthma and discuss the cellular and molecular mechanisms that control Th2 cell differentiation in the respiratory tract. Based on the steps in Tn cell development, we discuss how traditional therapies can modulate Th2 cell function. Furthermore, we explore newer immunomodulatory strategies to inhibit Th2 cell effects, including therapies that may block Th2 cell differentiation, neutralize cytokines, and redirect immune responses towards Th1 and away from Th2. (C) 2000 Elsevier Science Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available